Quick Listen: Scrip's Five Must-Know Things
Executive Summary
Join us for a quick audio roundup of five useful things to know from Scrip's recent coverage of the global biopharma industry.
A new bite-size podcast provides a brief audio tour around Scrip's Five Must-Know Things, starting off for the week ended 19 July.
This time we provide easy to digest updates around Operation Warp Speed, diversity in the biopharma industry, shifting commercial models, new results in psoriasis, and the future of cell and gene therapies.
Stories mentioned in this podcast:
(Also see "Operation Warp Speed Shortlist Not Decided Yet, Says Novavax" - Scrip, 15 Jun, 2020.)
(Also see "Leading A Diverse Company: Biopharma Executives Offer Ways Forward" - Scrip, 12 Jun, 2020.)
(Also see "Commercial Models Shifting As Pharma Mulls Digital-First Launches" - Scrip, 16 Jun, 2020.)
(Also see "Can UCB's Bimekizumab Go From Last To First In Psoriasis?" - Scrip, 15 Jun, 2020.)
(Also see "The Future Of Medicine: Cell And Gene Therapies Take The Lead" - Scrip, 11 Jun, 2020.)